Qiagen (QGEN) insider plans to sell 50,000 performance shares via Morgan Stanley

Rhea-AI Filing Summary

Qiagen N.V. (QGEN) disclosure shows a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $2,456,435.00. With 216,556,000 shares outstanding, the proposed block represents roughly 0.023% of the company. The shares were received as performance shares on 02/21/2023 (15,378 shares) and 02/28/2023 (34,622 shares). The filing reports “Nothing to Report” for sales in the past three months and includes the seller's attestation that they are not aware of undisclosed material adverse information.

Positive

• Transparent disclosure of a planned insider sale of 50,000 shares valued at $2,456,435.00
• Securities originated as performance shares (dates: 02/21/2023 and 02/28/2023), indicating award-based holdings rather than open-market purchases

Negative

• None.

Insights

Securities Analyst

TL;DR: Proposed sale is small relative to market cap; disclosure is routine and likely immaterial to share supply or price.

The Form 144 notifies the market of a planned sale of 50,000 QGEN common shares valued at $2.46M executed via Morgan Stanley Smith Barney LLC. That quantity equals about 0.023% of the 216.56M shares outstanding, so the transaction is unlikely to affect liquidity or valuation materially. The shares originate from performance awards granted in February 2023, and no prior sales were reported in the last three months, reducing near-term signaling risk.

Corporate Governance Expert

TL;DR: Filing reflects compliance with insider disclosure rules; governance impact is limited given the small size and award-based origin of shares.

The notice documents the seller's representation regarding material nonpublic information and identifies the broker. Because the shares derive from performance awards, the sale appears administrative rather than opportunistic. From a governance perspective, the form provides transparency required under Rule 144 but does not indicate management changes, regulatory issues, or other governance events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	2456435.00	216556000	08/13/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/21/2023	Performance Shares	Issuer			15378	02/21/2023	Not Applicable
Common	02/28/2023	Performance Shares	Issuer			34622	02/28/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the QGEN Form 144 disclose?

The filing proposes the sale of 50,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $2,456,435.00.

How large is the proposed sale relative to Qiagen's outstanding shares (QGEN)?

The company has 216,556,000 shares outstanding, so the proposed 50,000 share sale is about 0.023% of outstanding shares.

When were the shares being sold acquired?

The securities were acquired as performance shares on 02/21/2023 (15,378 shares) and 02/28/2023 (34,622 shares).

Does the filing report recent insider sales for QGEN?

The Form 144 states "Nothing to Report" for securities sold during the past three months.

Which broker is handling the proposed sale?

The named broker is Morgan Stanley Smith Barney LLC, located at Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004.

Does the filer attest to being aware of material nonpublic information?

Yes. The filing includes the seller's representation that they do not know any material adverse information about the issuer that has not been publicly disclosed.